February 28th, 2011

You are browsing the archive for February 28th, 2011.

Despite X-Ray Accidents, Lawmakers Fail to Set Standards for Technicians

Botched X-rays can shower patients with dangerous doses of radiation. Yet efforts by hospitals and regulators to maintain minimum standards of competence for technicians operating imaging machines have fallen short. The longstanding worries about X-ray foulups, along with the elevated dangers posed by more complicated medical devices such as CT scanners and linear accelerators, for ... Read more »

Pediatricians Urge Ban on Tanning Parlors for Children

Doctors are turning up the heat on regulators to ban teenagers and younger children from using tanning beds and other techniques to give the body an artificial bronze. The American Academy of Pediatrics on Monday weighed in on artificial tanning — a popular ritual among many teenagers, but one that can raise the risk of ... Read more »

Water Supplies Endangered by Radioactive Materials From Fracking

Environmentalists lately have grown increasingly concerned about groundwater contamination from a drilling technique known as hydraulic fracturing, or fracking. The technique, which has spiked in popularity since 2008, involves blasting water laced with sand and chemicals into underground rock formations to open up cracks that help extract difficult-to-reach reserves of natural gas. Yet the danger ... Read more »

Tobacco Giants Sue to Stop Possible Ban on Menthol Cigarettes

In an aggressive move to stave off a possible ban on menthol cigarettes, two tobacco companies have sued the Food and Drug Administration, alleging that some members of its tobacco advisory committee have conflicts of interest. The Tobacco Products Scientific Advisory Committee was due to issue by March 23 its non-binding recommendation on whether menthol ... Read more »

Genentech Gets Another Shot to Save Avastin as a Breast Cancer Drug

The maker of  Avastin — the world’s best-selling cancer drug — will get a chance to try to overturn the recommendation of regulators that it no longer be used to treat breast cancer. The Food and Drug Administration has scheduled a first-of-its-kind public hearing for June 28-29 at which Genentech Inc. can make its case ... Read more »